US 11352403
Activatable interleukin-2 polypeptides and methods of use thereof
granted A61KA61K38/00A61P
Quick answer
US patent 11352403 (Activatable interleukin-2 polypeptides and methods of use thereof) held by Werewolf Therapeutics, Inc. expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Werewolf Therapeutics, Inc.
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00